These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37542099)

  • 1. In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines.
    Molenaar-de Backer MWA; Doodeman P; Rezai F; Verhagen LM; van der Ark A; Plagmeijer EM; Metz B; van Vlies N; Ophorst O; Raeven RHM
    Sci Rep; 2023 Aug; 13(1):12675. PubMed ID: 37542099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
    Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
    Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component
    Carson D; Myhill S; Palmieri E; Necchi F; Rijpkema S; Micoli F; Nordgren IK; Rossi O; Vipond C
    Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34202832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study.
    Studholme L; Sutherland J; Desai T; Hockley J; Care R; Nordgren IK; Vipond C;
    Vaccine; 2019 Jun; 37(29):3761-3769. PubMed ID: 31202504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.
    Gimenes I; Caldeira C; Presgrave OA; de Moura WC; Villas Boas MH
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):356-60. PubMed ID: 26232706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT).
    da Silva CC; Presgrave OA; Hartung T; de Moraes AM; Delgado IF
    Toxicol In Vitro; 2016 Apr; 32():70-5. PubMed ID: 26688320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccines.
    Vipond C; Findlay L; Feavers I; Care R
    ALTEX; 2016; 33(1):47-53. PubMed ID: 26626274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products.
    Kim JH; Jung K; Kim J; Lee J; Kim H; Song H; Han K; Park S; Ahn C; Kim CW
    Biologicals; 2021 Jun; 71():20-30. PubMed ID: 33994086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans.
    Rossi O; Citiulo F; Mancini F
    Hum Vaccin Immunother; 2021 Feb; 17(2):601-613. PubMed ID: 32687736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of pyrogen detection tests in the quality control of meningococcal conjugate vaccines: The applicability of the Monocyte Activation Test.
    Fernandes Silva V; da Silva Guedes Junior D; da Silveira IA; Santos Almeida A; de Paiva Conte F; Fernandes Delgado I; Caldeira Silva C; França Presgrave OA; Antunes de Mattos K
    Altern Lab Anim; 2018 Nov; 46(5):255-272. PubMed ID: 30488711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a monocyte activation test for the control/safety testing of an OMV-based meningococcal B vaccine.
    Vipond C; Sutherland J; Nordgren K; Kemp G; Heath A; Care R; Studholme L
    Vaccine; 2019 Jun; 37(29):3747-3753. PubMed ID: 31202503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of pyrogenicity testing: Phasing out the rabbit pyrogen test. A meeting report.
    Cirefice G; Schütte K; Spreitzer I; Charton E; Shaid S; Viviani L; Rubbrecht M; Manou I
    Biologicals; 2023 Nov; 84():101702. PubMed ID: 37643507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pyrogen assays by testing products exhibiting low endotoxin recovery.
    Thurman TL; Lahti CJ; Mateffy JM; Forng RY; von Wintzingerode F; Silva LM; Deutschmann SM; Mozier N
    ALTEX; 2023; 40(1):117-124. PubMed ID: 35796330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine.
    Etna MP; Giacomini E; Rizzo F; Severa M; Ricci D; Shaid S; Lambrigts D; Valentini S; Galli Stampino L; Alleri L; Gaggioli A; Von Hunolstein C; Spreitzer I; Coccia EM
    ALTEX; 2020; 37(4):532-544. PubMed ID: 32488289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests.
    Pardo-Ruiz Z; Menéndez-Sardiñas DE; Pacios-Michelena A; Gabilondo-Ramírez T; Montero-Alejo V; Perdomo-Morales R
    Eur J Pharm Sci; 2016 Jan; 81():18-26. PubMed ID: 26428698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulated Expression of
    Pérez-Ortega J; van Boxtel R; de Jonge EF; Tommassen J
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
    Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing.
    Valente Pinto M; Davis K; Andrews N; Goldblatt D; Borrow R; Southern J; Nordgren IK; Vipond C; Plested E; Miller E; Snape MD
    Vaccine; 2020 Nov; 38(49):7834-7841. PubMed ID: 33109390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity.
    Dowling DJ; Sanders H; Cheng WK; Joshi S; Brightman S; Bergelson I; Pietrasanta C; van Haren SD; van Amsterdam S; Fernandez J; van den Dobbelsteen GP; Levy O
    Front Immunol; 2016; 7():562. PubMed ID: 28008331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
    Borton LK; Coleman KP
    ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.